TWO RESEARCH ACTIVITIES

EASL CLIF CHAIR

Performs clinical studies to improve the diagnosis and treatment of patients with Chronic Liver Failure (CLIF).

READ MORE

GRIFOLS CHAIR FOR TRANSLATIONAL
RESEARCH

Promotes translational research studies in Chronic Liver Failure (CLIF).

READ MORE

NEWS&EVENTS

May 30, 2023 Differences in percentage of Native American ancestry are associated with the odds to develop severe acute-on-chronic liver failure and risk of short-term mortality in the Latin American population A large prospective observational study carried out in Latin America finds high prevalence of severe acute-on-chronic liver failure and high risk of 28-day mortality in patients hospitalized for acute decompensation of cirrhosis with a higher percentage of Native American ancestry (and reported race) than that of European and African descent.

BARCELONA—The basis of genetic ancestry (and race) underlying differences in disease occurrence, outcomes or response to treatment remains unclear and most often racial and ethnic diversity is underrepresented in clinical research contributing to further expand the gap of health inequities. According to the Global Burden of Disease 2010 study, complications of cirrhosis accounted for 1 million deaths worldwide and caused 31 million disability adjusted life years (DALYs) that year. Noteworthy, liver cirrhosis mortality in Mexico was the highest in Latin America in 2010 with a mortality rate of 38.3 per 100,000. Patients with acute decompensation of cirrhosis suddenly develop ascites, hepatic encephalopathy, gastrointestinal hemorrhage, or any combination thereof. The CANONIC study, the first large, observational study carried out in Europe by the European Association for the Study of the Liver-Chronic Liver Failure (EASL-CLIF) Consortium, identified acute-on-chronic liver failure (ACLF) as a distinct syndrome that develops in 30% of patients with acute decompensation of cirrhosis, and is characterized by acute systemic inflammation, multi-system organ failure, and a high risk of death within 28 days after hospital admission. The ACLARA study – Prevalence, epidemiology, characterization and mechanism of ACLF in Latin America – sheds new light on the potential impact of genetic ancestry and reported race on the severity of ACLF and risk of short-term mortality. The study carried out in 1274 patients non-electively hospitalized for acute decompensation of cirrhosis in 44 university hospitals from 27 cities in 7 Latin American countries (Argentina, Brazil, Chile, Colombia, Mexico, Paraguay, and Peru), highlights the importance of including genetic ancestry (and race) in liver disease research and clinical practice for being variables that capture relevant epidemiological information. Findings from this study, published ahead of print in Gastroenterology, show that social factors (i.e., admission to public hospitals compared to private hospitals) and markers of organ function independently correlate with higher short-term mortality. The data also suggest an association between increased percentage of Native American ancestry (and reported race) and development of ACLF independent of alcohol-related hepatitis and bacterial infections, two major precipitant events of acute decompensation of cirrhosis and progression to ACLF.

READ MORE
May 16, 2023 A CHANCE for researchers to win a registration for The Liver Meeting 2023 We call all investigators in CHANCE to help us reach the 1000th patient milestone

The CHANCE study aims to recruit 2000 patients by the end of 2023. With 58 actively recruiting centers in 20 countries across the world, we are confident that CHANCE will render positive results and provide answers to our primary objective: To compare 1-year graft and patient survival rates after liver transplantation in patients with acute-on-chronic liver failure (ACLF) grade 2 or 3 at the time of liver transplantation with patients with decompensated cirrhosis without ACLF and transplant-free survival of patients with ACLF grade 2 or 3 not listed for liver transplantation.

READ MORE
May 05, 2023 CHANCE investigators meet on the occasion of ILTS 2023 in Rotterdam, The Netherlands Having reached a mid-point in the CHANCE study, the 4th CHANCE Investigator Meeting reunited investigators across participating centers to discuss about project progress on 4 May 2023 in Rotterdam, The Netherlands.

ROTTERDAM—The 4th CHANCE Investigator Meeting took place in Rotterdam, The Netherlands on the occasion of the 2023 International Congress of ILTS, ELITA and LICAGE (ILTS 2023). The CHANCE investigator meeting brought together 35 investigators and professionals from 12 countries (Argentina, Austria, Canada, France, Germany, India, Italy, Japan, Spain, The Netherlands, UK, and USA), 22 people attended in person and 13 joined online, to review and discuss project progress and address challenges of patient recruitment and data collection.

READ MORE
February 23, 2023 Celebrating 10 years of CANONIC: It's all about improving care and survival for patients with ACLF To celebrate 10 years since the publication of results from the CANONIC study, we talked with Prof. Richard Moreau, leading researcher in this prospective observational investigation, about the impact of chronic liver disease, approaches to treatment, and best practices.

The CANONIC study – European Association for the Study of the Liver (EASL)–Chronic Liver Failure (CLIF) Consortium acute-on-chronic liver failure in cirrhosis – was unprecedented in its scope and findings providing the means for the first evidence-based definition of the syndrome referred to as "acute-on-chronic liver failure" (ACLF). Although no universal definition of ACLF has been yet recognized, the EASL-CLIF Consortium diagnostic criteria has been applied and validated worldwide. Results from the CANONIC study opened up a new venue of liver disease research that will continue expanding in the following years.

READ MORE
February 17, 2023 International Day of Women and Girls in Science: Debbie Shawcross Meet Debbie Shawcross, MD, PhD, Professor of Hepatology and Chronic Liver Failure at King's College London and King's College Hospital NHS Foundation Trust, UK, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 16, 2023 International Day of Women and Girls in Science: Dominique Thabut Meet Dominique Thabut, MD, PhD, Professor in Hepatology, Intensive Care Unit at the Pitié-Salpêtière Hospital AP-HP, Sorbonne Université, France, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 16, 2023 International Day of Women and Girls in Science: Vanessa Stadlbauer-Köllner Meet Vanessa Stadlbauer-Köllner, MD, Associate Professor at the Medical University of Graz, Internal Medicine and Hepatology-Gastroenterology consultant at the University Hospital Graz, Austria, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 14, 2023 International Day of Women and Girls in Science: Meritxell Ventura-Cots Meet Meritxell Ventura-Cots, MD, PhD, staff member and clinical researcher at Hospital Universitari Vall d'Hebron, Spain, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 11, 2023 International Day of Women and Girls in Science: Sara Montagnese Meet Sara Montagnese, MD, PhD, Associate Professor of Internal Medicine at University of Padova, Italy, Professor of Chronobiology at University of Surrey, UK, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 10, 2023 International Day of Women and Girls in Science: Rosa Martín-Mateos Meet Rosa Martín-Mateos, MD, PhD, Consultant at Hospital Universitario Ramón y Cajal and Researcher at Universidad de Alcalá - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), CIBERehc, Instituto de Salud Carlos III, Spain, and member of our Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
February 08, 2023 International Day of Women and Girls in Science: Ingrid Zhang Meet Ingrid Zhang, MD, PhD, Research Fellow of the Clinician Scientist Program supported by the Berlin Institute of Health in the Department of Hepatology and Gastroenterology at Charité – Universitätsmedizin Berlin, Germany, and member of the EF CLIF Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, Ingrid gives insights into her work and shares her hopes and research goals as a scientist.

READ MORE
February 07, 2023 International Day of Women and Girls in Science: Virginia Hernández-Gea Meet Virginia Hernández-Gea, MD, PhD, Senior Specialist in Hepatology at Hospital Clínic de Barcelona-IDIBAPS, Spain, and member of our recently established Inspiring and Writing Group.

In celebration of International Day of Women and Girls in Science, we want to raise awareness of the work of women in hepatology and inspire the next generation of budding scientists.

READ MORE
January 23, 2023 The 5th MICROB-PREDICT General Assembly brings together members of the consortium to review next steps in the ALB trial startup process The MICROB-PREDICT General Assembly is an annual flagship event within the MICROB-PREDICT Consortium that brings together active members, work package leaders, and representatives of the different advisory committees and boards to assess project progress and exchange knowledge and ideas.

BARCELONA—The 5th MICROB-PREDICT General Assembly meeting took place in Budapest, Hungary, from 17 to 19 January 2023. Partners from 16 institutions in 10 countries met to review progress within MICROB-PREDICT and set the ALB trial up for success.

READ MORE
January 11, 2023 Meet our new trustee, Ignasi Bruguer We recently welcomed Ignasi Bruguer to our Board of Trustees.

READ MORE